Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated

Psychological Medicine

Volumn 44, Issue 6, 2014, Pages 1267-1277

  Tang, S X ^a   Yi, J J ^b   Calkins, M E ^a   Whinna, D A ^a   Kohler, C G ^a   Souders, M C ^b   McDonald McGinn, D M ^b   Zackai, E H ^a,b   Emanuel, B S ^a,b   Gur, R C ^a   Gur, R E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

22q11.2 deletion syndrome; psychopathology; psychosis; treatment

Indexed keywords

ADOLESCENT; ADULT; ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COMPLICATION; DIGEORGE SYNDROME; FEMALE; HUMAN; MALE; MENTAL HEALTH SERVICE; MIDDLE AGED; MOOD DISORDERS; PREVALENCE; PSYCHOTIC DISORDERS; STATISTICS AND NUMERICAL DATA; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DIGEORGE SYNDROME; FEMALE; HUMANS; MALE; MENTAL HEALTH SERVICES; MIDDLE AGED; MOOD DISORDERS; PREVALENCE; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 84926093079     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291713001669     Document Type: Article

References (33)

1. Antshel KM, Fremont W, Roizen NJ, Shprintzen R, Higgins AM, Dhamoon A, Kates WR (2006). ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 45, 596-603.
2. Antshel KM, Shprintzen R, Fremont W, Higgins AM, Faraone SV, Kates WR (2010). Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome: a 3-year follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry 49, 333-344.
3. Bassett AS, Chow EW (2008). Schizophrenia and 22q11.2 deletion syndrome. Current Psychiatry Reports 10, 148-157.
4. Bassett AS, Chow EW, Abdel Malik P, Gheorghiu M, Husted J, Weksberg R (2003). The schizophrenia phenotype in 22q11 deletion syndrome. American Journal of Psychiatry 160, 1580-1586.
5. Bassett AS, McDonald-McGinn DM, Devriendt K, Digilio MC, Goldenberg P, Habel A, Marino B, Oskarsdottir S, Philip N, Sullivan K, Swillen A, Vorstman J; International 22q11.2 Deletion Syndrome Consortium (2011). Practical guidelines for managing patients with 22q11.2 deletion syndrome. Journal of Pediatrics 159, 332-9.e1.
6. Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, Merritt RK, O'Leary LA, Wong L-Y, Elixson EM (2003). A population-based study of the 22q11. 2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112, 101-107.
7. Dreessen L, Arntz A (1998). Short-interval test-retest interrater reliability of the Structured Clinical Interview for DSM-III-R personality disorders (SCID-II) in outpatients. Journal of Personality Disorders 12, 138-148.
8. Fabbro A, Rizzi E, Schneider M, Debbane M, Eliez S (2012). Depression and anxiety disorders in children and adolescents with velo-cardio-facial syndrome (VCFS). European Child and Adolescent Psychiatry 21, 379-385.
9. First MB, Gibbon M (2004). The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II). In Comprehensive Handbook of Psychological Assessment. Vol. 2, Personality Assessment (ed. M. J. Hilsenroth and D. L. Segal), pp. 134-143. John Wiley & Sons, Inc.: Hoboken, NJ.
10. Goldenberg PC, Calkins ME, Richard J, McDonald-McGinn D, Zackai E, Mitra N, Emanuel B, Devoto M, Borgmann-Winter K, Kohler C, Conroy CG, Gur RC, Gur RE (2012). Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 159B, 87-93.
11. Gothelf D, Feinstein C, Thompson T, Gu E, Penniman L, Van Stone E, Kwon H, Eliez S, Reiss AL (2007). Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. American Journal of Psychiatry 164, 663-669.
12. Green T, Gothelf D, Glaser B, Debbane M, Frisch A, Kotler M, Weizman A, Eliez S (2009). Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 48, 1060-1068.
13. Gur RE, Kohler C, Turetsky BI, Siegel SJ, Kanes SJ, Bilker WB, Brennan AR, Gur RC (2004). A sexually dimorphic ratio of orbitofrontal to amygdala volume is altered in schizophrenia. Biological Psychiatry 55, 512-517.
14. Hafner H, an der Heiden W, Behrens S, Gattaz WF, Hambrecht M, Loffler W, Maurer K, Munk-Jorgensen P, Nowotny B, Riecher-Rossler A, Stein A (1998). Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophrenia Bulletin 24, 99-113.
15. Jawad AF, McDonald-McGinn DM, Zackai E, Sullivan KE (2001). Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Journal of Pediatrics 139, 715-723.
16. Jolin EM, Weller RA, Jessani NR, Zackai EH, McDonald-McGinn DM, Weller EB (2009). Affective disorders and other psychiatric diagnoses in children and adolescents with 22q11.2 deletion syndrome. Journal of Affective Disorders 119, 177-180.
17. Jolin EM, Weller RA, Weller EB (2012). Occurrence of affective disorders compared to other psychiatric disorders in children and adolescents with 22q11.2 deletion syndrome. Journal of Affective Disorders 136, 222-228.
18. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N (1997). Schedule for Affective Disorders and Schizophrenia for School-Age Children - Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry 36, 980-988.
19. McDonald-McGinn DM, Minugh-Purvis N, Kirschner RE, Jawad A, Tonnesen MK, Catanzaro JR, Goldmuntz E, Driscoll D, Larossa D, Emanuel BS, Zackai EH (2005). The 22q11.2 deletion in African-American patients: an underdiagnosed population? American Journal of Medical Genetics. Part A 134, 242-246.
20. McDonald-McGinn DM, Tonnesen MK, Laufer-Cahana A, Finucane B, Driscoll DA, Emanuel BS, Zackai EH (2001). Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net! Genetics in Medicine 3, 23-29.
21. Merikangas KR, He J-P, Rapoport J, Vitiello B, Olfson M (2013). Medication use in US youth with mental disorders. JAMA Pediatrics 167, 141-148.
22. Merikangas KR, He MJ-P, Burstein M, Swanson MSA, Avenevoli S, Cui ML, Benjet C, Georgiades K, Swendsen J (2010). Lifetime prevalence of mental disorders in US adolescents: results from the National Comorbidity Study - Adolescent Supplement (NCS-A). Journal of the American Academy of Child and Adolescent Psychiatry 49, 980-989.
23. Michaelovsky E, Frisch A, Carmel M, Patya M, Zarchi O, Green T, Basel-Vanagaite L, Weizman A, Gothelf D (2012). Genotype-phenotype correlation in 22q11.2 deletion syndrome. BMC Medical Genetics 13, 122.
24. Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW (2003). Prodromal assessment with the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: predictive validity, interrater reliability, and training to reliability. Schizophrenia Bulletin 29, 703-715.
25. Murphy KC, Jones LA, Owen MJ (1999). High rates of schizophrenia in adults with velo-cardio-facial syndrome. Archives of General Psychiatry 56, 940-945.
26. Niklasson L, Rasmussen P, Oskarsdóttir S, Gillberg C (2009). Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Research in Developmental Disabilities 30, 763-773.
27. Schreiner MJ, Lazaro MT, Jalbrzikowski M, Bearden CE (2013). Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome. Neuropharmacology 68, 157-173.
28. Shapiro DI, Cubells JF, Ousley OY, Rockers K, Walker EF (2011). Prodromal symptoms in adolescents with 22q11.2 deletion syndrome and schizotypal personality disorder. Schizophrenia Research 129, 20-28.
29. Stoddard J, Niendam T, Hendren R, Carter C, Simon TJ (2010). Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome. Schizophrenia Research 118, 118-121.
30. Veerapandiyan A, Abdul-Rahman OA, Adam MP, Lyons MJ, Manning M, Coleman K, Kobrynski L, Taneja D, Schoch K, Zimmerman HH, Shashi V (2011). Chromosome 22q11.2 deletion syndrome in African-American patients: a diagnostic challenge. American Journal of Medical Genetics. Part A 155A, 2186-2195.
31. Vorstman JA, Morcus ME, Duijff SN, Klaassen PW, Heineman-de Boer JA, Beemer FA, Swaab H, Kahn RS, van Engeland H (2006). The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. Journal of the American Academy of Child and Adolescent Psychiatry 45, 1104-1113.
32. Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, Savage M, Platt LD, Saltzman D, Grobman WA, Klugman S, Scholl T, Simpson JL, McCall K, Aggarwal VS, Bunke B, Nahum O, Patel A, Lamb AN, Thom EA, Beaudet AL, Ledbetter DH, Shaffer LG, Jackson L (2012). Chromosomal microarray versus karyotyping for prenatal diagnosis. New England Journal of Medicine 367, 2175-2184.
33. Wilkinson GS, Robertson GJ (2006). Wide Range Achievement Test, Fourth Edition (WRAT4). Psychological Assessment Resources: Lutz, FL.